iBio

IBIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$85.529 M

$1.33 +5.56%

Close of 22 Sept 2026

Revenue

$400.0K

#3543 by revenue

Earnings

-$18.4M

Loss-making

Shares outstanding

49,678,561

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#316Telomir PharmaceuticalsTELO$86.0M
#317Adicet BioACET$85.6M
#318iBioIBIO$85.5M
#319Gain TherapeuticsGANX$85.1M
#320Aldeyra TherapeuticsALDX$84.2M

What if iBio were worth as much as…

Open the what-if tool →

Gold $30.2T

$470,148.65

Per share 353,495× higher

Bitcoin $1.74T

$27,083.34

Per share 20,363× higher

Nvidia $5.52T

$85,772.08

Per share 64,490× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for iBio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.